Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis
NCT01743404
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Carotid Atherosclerosis
Interventions
DIETARY_SUPPLEMENT:
Inflaminat
DRUG:
Placebo
Sponsor
Institute for Atherosclerosis Research, Russia